Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TRV027 / Trevena
NECTAR, NCT04924660: Novel Experimental COVID-19 Therapies Affecting Host Response	Completed	2/3	871	US	TXA127, TRV027, Placebo, Fostamatinib	Sean Collins, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)	COVID-19, SARS-CoV-2 Infection, Coronavirus Infection	10/23	12/23